Delivery Order SPE2DB22D3102-SPE2DB25FL2YH
Award Date 9/10/25
Potential Completion Date 9/11/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,101.85 to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/ml pen/ml, a pharmaceutical product used in migraine treatment. This firm fixed price delivery order, issued on September 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,074.80 firm fixed price delivery order for Emgality 120 mg/ml pen, a migraine treatment medication. Issued on August 1, 2025, this non-set-aside contract will be completed by August 4, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.00 to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen/mL, a pharmaceutical product used in migraine treatment. The contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, using firm fixed pricing with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,034.80 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors. This firm fixed-price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 29, 2025, for Emgality 120 mg/ml pen injectors valued at $1,037.40. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of July 30, 2025. The order is being funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,065.51 to AmerisourceBergen Drug Corp for Emgality 250 mg/2 mL pen (2 mL) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/mL pen injectors, with a ceiling value of $6,822.36. This firm fixed-price delivery order, awarded on August 19, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen will perform this supply delivery from its...
- The Defense Logistics Agency awarded a $1,729.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Emgality 120 mg/ml Penml, a medication used to treat migraine. The award has a ceiling value of $1,383.20 and a period of performance through March 31, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
- The Defense Logistics Agency awarded a delivery order valued at $3,116.22 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Emgality 120 mg/ml in pen format. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open competition process. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. Emgality is a monoclonal antibody treatment...